GlassScriptPhysician profile
Daniel B Hanna
NPI 1295362457
$2,811.28
in general payments reported to CMS, 2019-2025
18 companies · $1,592 in 2025
The $1,592 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.67 · 2022: $79.64 · 2023: $29.97 · 2024: $1,096 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,717.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $464.23 | 2024-2025 | Amvuttra, Onpattro |
| Medtronic, INC. | $351.69 | 2025 | Azure Xt Dr Mri Surescan, Omniasecure Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abiomed | $344.27 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.63 | 2024-2025 | Lifevest |
| Pfizer INC. | $280.28 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $182.78 | 2024-2025 | Wainua |
| Astellas Pharma US INC | $162.22 | 2024-2025 | |
| Novo Nordisk INC | $136.16 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $135.64 | 2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.03 | 2024 | Jardiance |
| Amgen INC. | $68.78 | 2022-2024 | Repatha, Otezla |
| Esperion Therapeutics, INC. | $63.73 | 2024-2025 | Nexletol |
| Lilly USA, LLC | $55.66 | 2021-2022 | |
| Bridgebio Pharma, INC. | $50.17 | 2025 | Attruby |
| Scpharmaceuticals INC. | $41.39 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $33.90 | 2025 | Carto 3 |
| Terumo Medical Corporation | $23.41 | 2024 | Metacross Otw, Tr Band |
| Alcon Vision LLC | $14.31 | 2023 | Total30 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.